Literature DB >> 25786480

Third-generation cephalosporin resistance conferred by a chromosomally encoded blaCMY-23 gene in the Escherichia coli ST131 reference strain EC958.

Minh-Duy Phan1, Kate M Peters1, Sohinee Sarkar1, Brian M Forde1, Alvin W Lo1, Mitchell Stanton-Cook1, Leah W Roberts1, Mathew Upton2, Scott A Beatson1, Mark A Schembri3.   

Abstract

OBJECTIVES: Escherichia coli ST131 is a globally disseminated MDR clone originally identified due to its association with the blaCTX-M-15 gene encoding an ESBL. It is thus assumed that blaCTX-M-15 is the major determinant for resistance to β-lactam antibiotics in this clone. The complete sequence of EC958, a reference strain for E. coli ST131, revealed that it contains a chromosomally located blaCMY-23 gene with an upstream ISEcp1 element as well as several additional plasmid-encoded β-lactamase genes. Here, we examined the genetic context of the blaCMY-23 element in EC958 and other E. coli ST131 strains and investigated the contribution of blaCMY-23 to EC958 resistance to a range of β-lactam antibiotics.
METHODS: The genetic context of blaCMY-23 and its associated mobile elements was determined by PCR and sequencing. Antibiotic susceptibility testing was performed using Etests. The activity of the blaCMY-23 promoter was assessed using lacZ reporter assays. Mutations were generated using λ-Red-recombination.
RESULTS: The genetic structure of the ISEcp1-IS5-blaCMY-23 mobile element was determined and localized within the betU gene on the chromosome of EC958 and five other E. coli ST131 strains. The transcription of blaCMY-23, driven by a previously defined promoter within ISEcp1, was significantly higher than other β-lactamase genes and could be induced by cefotaxime. Deletion of the blaCMY-23 gene resulted in enhanced susceptibility to cefoxitin, cefotaxime and ceftazidime.
CONCLUSIONS: This is the first known report to demonstrate the chromosomal location of blaCMY-23 in E. coli ST131. In EC958, CMY-23 plays a major role in resistance to third-generation cephalosporins and cephamycins.
© The Author 2015. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  AmpC β-lactamases; E. coli ST131; antibiotic resistance

Mesh:

Substances:

Year:  2015        PMID: 25786480     DOI: 10.1093/jac/dkv066

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  4 in total

1.  Genomic Comparison Reveals Natural Occurrence of Clinically Relevant Multidrug-Resistant Extended-Spectrum-β-Lactamase-Producing Escherichia coli Strains.

Authors:  Lin Teng; Shinyoung Lee; Amber Ginn; Sarah M Markland; Raies A Mir; Nicolas DiLorenzo; Christina Boucher; Mattia Prosperi; Judith Johnson; J Glenn Morris; Kwangcheol C Jeong
Journal:  Appl Environ Microbiol       Date:  2019-06-17       Impact factor: 4.792

Review 2.  Molecular Characterization of the Multidrug Resistant Escherichia coli ST131 Clone.

Authors:  Mark A Schembri; Nouri L Ben Zakour; Minh-Duy Phan; Brian M Forde; Mitchell Stanton-Cook; Scott A Beatson
Journal:  Pathogens       Date:  2015-06-26

3.  MinION nanopore sequencing identifies the position and structure of bacterial antibiotic resistance determinants in a multidrug-resistant strain of enteroaggregative Escherichia coli.

Authors:  David R Greig; Timothy J Dallman; Katie L Hopkins; Claire Jenkins
Journal:  Microb Genom       Date:  2018-09-20

4.  Sequential Acquisition of Virulence and Fluoroquinolone Resistance Has Shaped the Evolution of Escherichia coli ST131.

Authors:  Nouri L Ben Zakour; Areej S Alsheikh-Hussain; Melinda M Ashcroft; Nguyen Thi Khanh Nhu; Leah W Roberts; Mitchell Stanton-Cook; Mark A Schembri; Scott A Beatson
Journal:  MBio       Date:  2016-04-26       Impact factor: 7.867

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.